vs
Side-by-side financial comparison of EVOLUTION PETROLEUM CORP (EPM) and Spero Therapeutics, Inc. (SPRO). Click either name above to swap in a different company.
EVOLUTION PETROLEUM CORP is the larger business by last-quarter revenue ($20.7M vs $12.6M, roughly 1.6× Spero Therapeutics, Inc.). Spero Therapeutics, Inc. runs the higher net margin — 250.7% vs 5.2%, a 245.5% gap on every dollar of revenue. On growth, Spero Therapeutics, Inc. posted the faster year-over-year revenue change (24080.8% vs 2.0%). Over the past eight quarters, Spero Therapeutics, Inc.'s revenue compounded faster (847.7% CAGR vs -5.2%).
EPM vs SPRO — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $20.7M | $12.6M |
| Net Profit | $1.1M | $31.5M |
| Gross Margin | 44.3% | — |
| Operating Margin | 3.2% | — |
| Net Margin | 5.2% | 250.7% |
| Revenue YoY | 2.0% | 24080.8% |
| Net Profit YoY | 158.4% | 250.9% |
| EPS (diluted) | $0.03 | $0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $20.7M | $12.6M | ||
| Q3 25 | $21.3M | $0 | ||
| Q2 25 | $21.1M | $0 | ||
| Q1 25 | $22.6M | $12.0K | ||
| Q4 24 | $20.3M | $52.0K | ||
| Q3 24 | $21.9M | $65.0K | ||
| Q2 24 | $21.2M | $114.0K | ||
| Q1 24 | $23.0M | $140.0K |
| Q4 25 | $1.1M | $31.5M | ||
| Q3 25 | $824.0K | $-7.4M | ||
| Q2 25 | $3.4M | $-1.7M | ||
| Q1 25 | $-2.2M | $-13.9M | ||
| Q4 24 | $-1.8M | — | ||
| Q3 24 | $2.1M | $-17.1M | ||
| Q2 24 | $1.2M | $-17.9M | ||
| Q1 24 | $289.0K | $-12.7M |
| Q4 25 | 44.3% | — | ||
| Q3 25 | 38.5% | — | ||
| Q2 25 | 46.1% | — | ||
| Q1 25 | 40.7% | — | ||
| Q4 24 | 36.9% | — | ||
| Q3 24 | 46.2% | — | ||
| Q2 24 | 46.3% | — | ||
| Q1 24 | 45.2% | — |
| Q4 25 | 3.2% | — | ||
| Q3 25 | -0.4% | — | ||
| Q2 25 | 6.3% | — | ||
| Q1 25 | 7.0% | -122758.3% | ||
| Q4 24 | -3.0% | — | ||
| Q3 24 | 8.5% | -28604.6% | ||
| Q2 24 | 11.3% | -16720.2% | ||
| Q1 24 | 9.1% | -9987.1% |
| Q4 25 | 5.2% | 250.7% | ||
| Q3 25 | 3.9% | — | ||
| Q2 25 | 16.2% | — | ||
| Q1 25 | -9.7% | -115550.0% | ||
| Q4 24 | -9.0% | — | ||
| Q3 24 | 9.4% | -26380.0% | ||
| Q2 24 | 5.8% | -15668.4% | ||
| Q1 24 | 1.3% | -9049.3% |
| Q4 25 | $0.03 | $0.56 | ||
| Q3 25 | $0.02 | $-0.13 | ||
| Q2 25 | $0.10 | $-0.03 | ||
| Q1 25 | $-0.07 | $-0.25 | ||
| Q4 24 | $-0.06 | — | ||
| Q3 24 | $0.06 | $-0.32 | ||
| Q2 24 | $0.04 | $-0.33 | ||
| Q1 24 | $0.01 | $-0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.8M | $40.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $67.5M | $59.0M |
| Total Assets | $169.3M | $68.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.8M | $40.3M | ||
| Q3 25 | $714.0K | $48.6M | ||
| Q2 25 | $2.5M | $31.2M | ||
| Q1 25 | $5.6M | $48.9M | ||
| Q4 24 | $11.7M | $52.9M | ||
| Q3 24 | $6.9M | $76.3M | ||
| Q2 24 | $6.4M | $63.5M | ||
| Q1 24 | $3.1M | $82.3M |
| Q4 25 | $67.5M | $59.0M | ||
| Q3 25 | $69.1M | $26.5M | ||
| Q2 25 | $71.8M | $32.8M | ||
| Q1 25 | $71.7M | $33.8M | ||
| Q4 24 | $76.3M | $46.1M | ||
| Q3 24 | $79.6M | $65.5M | ||
| Q2 24 | $81.1M | $80.5M | ||
| Q1 24 | $83.5M | $96.2M |
| Q4 25 | $169.3M | $68.9M | ||
| Q3 25 | $169.1M | $54.2M | ||
| Q2 25 | $160.3M | $62.1M | ||
| Q1 25 | $156.4M | $77.7M | ||
| Q4 24 | $160.2M | $110.5M | ||
| Q3 24 | $157.9M | $135.2M | ||
| Q2 24 | $162.9M | $149.9M | ||
| Q1 24 | $166.5M | $167.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $5.4M | $-8.4M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 5.09× | -0.26× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.4M | $-8.4M | ||
| Q3 25 | $7.8M | $17.4M | ||
| Q2 25 | $10.5M | $-17.7M | ||
| Q1 25 | $7.3M | $-4.0M | ||
| Q4 24 | $7.7M | $-23.4M | ||
| Q3 24 | $7.6M | $12.8M | ||
| Q2 24 | $8.0M | $-18.7M | ||
| Q1 24 | $3.4M | $5.9M |
| Q4 25 | 5.09× | -0.26× | ||
| Q3 25 | 9.47× | — | ||
| Q2 25 | 3.06× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.69× | — | ||
| Q2 24 | 6.47× | — | ||
| Q1 24 | 11.64× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EPM
| Crude Oil | $10.7M | 52% |
| Natural Gas Reserves | $7.4M | 36% |
| Natural Gas Liquids Reserves | $2.5M | 12% |
SPRO
Segment breakdown not available.
